approval
saveLOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
July 20, 2023updated 6mo ago
community read0 votes
Sponsor: IPCA LABS LTD. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 6mo ago
Found something off?
same company · ±60 days · 6
- approvalALDACTAZIDE: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalJul 28, 2023
- approvalALDACTAZIDE: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalJul 28, 2023
- approvalacetaminophen ER: TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalJun 7, 2023
- approvalALDACTAZIDE: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalJun 7, 2023
- approvaltramadol hydrochloride ER: TRAMADOL HYDROCHLORIDE — FDA approvalJun 7, 2023
- approvalolanzapine ODT: OLANZAPINE — FDA approvalJun 7, 2023
🐶 often sniffed alongside
top 8- companyMacleods Pharma USA Inc10 co-mentions · 4 sources
- tagRecall7 co-mentions · 4 sources
- drugEuthyrox3 co-mentions · 2 sources
- drugTirosint3 co-mentions · 2 sources
- drugLevolet3 co-mentions · 2 sources
- drugErmeza3 co-mentions · 2 sources
- drugLevoxyl3 co-mentions · 2 sources
- druglevothyroxine sodium3 co-mentions · 2 sources
comments(0)
5-min edit window · permanent after that